How lymph node changes affect rectal cancer outcomes
Part of Cancer, Digestive system clinical trials.
This trial looks at how much the lymph nodes respond to chemoradiation before surgery in people with locally advanced rectal cancer. It aims to understand if that response can predict long-term results and guide future treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with locally advanced rectal cancer (stage II or III).
- You completed chemoradiation (NCRT) followed by surgery to remove the cancer.
- Your doctors have before- and after-treatment tissue samples, including digital images of your tumor slides.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of removing lymph nodes (small glands that help fight infection) during robotic surgery for mid or low rectal cancer. It aims to see whether removing fewer lymph nodes may be just as effective and cause fewer side effects than removing a larger group of them.
This trial focuses on rectal cancer that has come back in the side lymph nodes near the pelvis. It tests how to treat that “lateral nodal recurrence” to improve outcomes by targeting these specific lymph nodes.
This study follows real-world treatment of locally advanced rectal cancer (cancer that has grown into nearby tissues but hasn't spread to distant organs) in patients who receive chemotherapy and/or radiation before surgery. Researchers track how different treatment approaches work to help improve outcomes.
This study looks at how your genes and radiation-related factors affect how well rectal cancer responds to chemo and radiation given before surgery. The goal is to help personalize treatment and predict outcomes for people with locally advanced rectal cancer.
This study looks at whether giving radiation or chemoradiation after removing an early-stage rectal cancer can improve outcomes for patients who choose not to have standard surgery to remove the whole rectum. It aims to see how well this approach works in real-world practice.
This study looks at where colorectal cancer spreads to lymph nodes after surgery. It aims to improve how doctors check lymph nodes to better understand the cancer and guide future treatment.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.